Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
Vous n'êtes pas connecté
Insulet (PODD) reports positive findings from the SECURE-T2D pivotal trial, the largest study of AID therapy in people with type 2 diabetes.
Insulet (PODD) debuts the Omnipod 5 AID system in France and announces new updates for the U.S. markets.
WEDNESDAY, June 26, 2024 -- The gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study...
MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening,...
People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from...
WEDNESDAY, June 26, 2024 -- The stress hormone cortisol appears to play a role in tough-to-treat type 2 diabetes, a new study finds. About 1 in 4...
WEDNESDAY, July 3, 2024 -- Semaglutide is associated with nonarteritic anterior ischemic optic neuropathy (NAION) among patients with type 2 diabetes...
TUESDAY, July 2, 2024 -- Two well-known healthy diets can lower heart disease risk in people with type 1 diabetes, a new study says. People who ate...
In the global health landscape, diabetes stands out as a prevalent and persistent challenge, affecting approximately 415 million people worldwide. The...